South Korean Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Myung In Pharmaceutical

Market Cap: ₩1.1t

A pharmaceutical company, manufactures ETC and OTC drugs.

GC Genome

Market Cap: ₩186.6b

Operates as a clinical genome analysis company in South Korea.

ISU Abxis

Market Cap: ₩240.1b

A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.

JW Lifescience

Market Cap: ₩218.5b

Provides national infusion solutions in South Korea and internationally.

NIBEC

Market Cap: ₩574.9b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Onconic Therapeutics

Market Cap: ₩800.8b

Engages in the research and development of anti-cancer therapy in South Korea.

Huons

Market Cap: ₩328.6b

Provides medical solutions for human health in Korea and internationally.

BioNote

Market Cap: ₩572.7b

Manufactures and sells in-vitro diagnostic animal medicines in South Korea.

NanoEntek

Market Cap: ₩160.9b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

Daihan PharmaceuticalLtd

Market Cap: ₩178.2b

Engages in the manufacture and sale of therapeutic drugs in South Korea.

Dong-A Socio Holdings

Market Cap: ₩787.7b

Engages in the pharmaceutical business in South Korea.